Features | Partner Sites | Information | LinkXpress
Sign In
FOCUS DIAGNOSTICS, INC.
RANDOX LABORATORIES
Bio-Rad Diabetes Division

Whole Genome Sequencing Better at Tracing TB Outbreaks

By Labmedica International staff writers
Posted on 25 Feb 2013
A study revealed that a new form of genetic testing of the bacteria that cause tuberculosis (TB) provides better information on TB transmission and thus allows tracing of TB outbreaks more accurately than the current standard tests.

A team of experts from public-health institutions, research institutes, and universities in Germany and France led by Stefan Niemann from the Forschungszentrum Borstel (Borstel, Germany) compared the results of the two types of tests on 86 Mycobacterium tuberculosis isolates from a TB outbreak in the German states Hamburg and Schleswig-Holstein (overall 2301 TB cases have been investigated in the study period from 1997 to 2010).

They found that the new test, based on the sequencing of the respective whole genomes (i.e., whole genome sequencing, WGS) provided more accurate information on clustering and temporal spread of the pathogen than the standard tests, which are based on the analysis of small genome regions (classical genotyping). Importantly, while standard tests were not able to distinguish the strains involved, WGS-based analyses revealed that only a particular clone started spreading at the onset of the outbreak, suggesting that subtle differences in the genome might influence the success of pathogen transmission.

"Only genome based investigations allowed us to trace the spread of M. tuberculosis with the resolution needed to visualize transmission patterns correctly," said Dr. Andreas Rötzer, first author of the study.

Genotyping of M. tuberculosis strains is usually used to detect TB outbreaks and guide tracing contacts of TB cases. However, standard genotyping analyses only tiny parts of the genome, and may therefore not be able to distinguish between closely related strains spreading in distinct transmission chains. This was confirmed by this study: WGS-based typing discriminated better the different strain variants involved in the outbreak, was in better agreement with information on known contacts between the patients, and allowed the investigators to more precisely follow the spread of clones over space and time.

Based on the genome sequencing data, the authors were also able to estimate that the genome of M. tuberculosis evolves in its natural host population (infected individuals) at a slower mutation rate than other bacterial pathogens (0.4 mutations per genome per year). This measure of the bacterium’s mutation rate will be useful to trace future outbreaks and estimate when and via which individual they originated.

An additional advantage of WGS compared to standard genotyping is that WGS allows the identification of mutations of bacterial genes causing antibiotic resistance mutations and variations in virulence genes. This is especially important as M. tuberculosis strains that are resistant to the most potent drugs are increasingly emerging in several world regions and rapid detection of resistance is crucial for successful treatment.

The costs of whole genome analysis based on Next Generation Sequencing are declining; therefore, this test could soon become the standard method for identifying transmission patterns and rates of infectious disease outbreaks.

In addition, the authors state: “We envision that the progressive effective implementation of WGS for Public Health and medical diagnostics will also be accelerated by the broader distribution of more accessible and flexible sequencing machines, and upcoming bioinformatics developments to facilitate quick and relevant interpretation of the resulting data by the clinical and medical staff.”

The study was published in PLOS Medicine on February 12, 2013.

Related Links:

Forschungszentrum Borstel



KARL HECHT GMBH & CO KG
77 ELEKTRONIKA
DIASYS DIAGNOSTIC SYSTEMS

Channels

Hematology

view channel

Magnetic Resonance Improves Approach to Measuring Hemostasis Parameters

Two studies evaluating a magnetic resonance based detector for hemostasis measurements found its multiplex results to be rapid and accurate using lower blood volumes. At the International Society on Thrombosis and Hemostasis (ISTH) 2015 Congress (Toronto, Canada), T2 Biosystems, Inc. (Lexington, MA, USA) presented results... Read more

Lab Tech.

view channel
Image: Verigene System instrumentation consists of a Verigene Reader and one or multiple Verigene Processor SPs (Photo courtesy of Nanosphere).

Directed Molecular Diagnostic Tests Highlight Recent Microbiology Conference

The performance of a series of directed molecular diagnostic tests was confirmed by several studies presented at a recent microbiology conference. Nanosphere (Northbrook, IL, USA) manufactures tests... Read more

Industry News

view channel

QIAGEN Expands Diagnostics Menu in Partnership with Seegene

In a new collaboration, Seegene Inc. (Soul, Republic of Korea) will use its proprietary next-generation qPCR technology in developing new multiplex assays for the flagship platform of Qiagen NV (Venlo, Netherlands and Hilden, Germany). Seegene will develop a menu of multiplex assay panels for the modular QIAsymphony... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.